Multicentre study found that adherence to national antibiotic recommendations for neonatal early-onset sepsis was low.


Journal

Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968

Informations de publication

Date de publication:
03 2021
Historique:
received: 12 04 2020
revised: 01 07 2020
accepted: 14 07 2020
pubmed: 21 7 2020
medline: 15 5 2021
entrez: 21 7 2020
Statut: ppublish

Résumé

Our aim was to evaluate adherence to the Dutch neonatal early-onset sepsis (EOS) guidelines, adapted from UK guidance. We also looked at the effect on antibiotic recommendations and duration. This was a multicentre, prospective observational cross-sectional study carried out in seven hospitals in the Netherlands between 1 September 2018 and 1 November 2019. We enrolled 1024 neonates born at 32 weeks of gestation or later if they demonstrated at least one EOS risk factor or clinical signs of infection. The Dutch guidelines recommended antibiotic treatment for 438/1024 (42.8%) of the neonates designated at risk, but only 186/438 (42.5%) received antibiotics. The guidelines advised withholding antibiotics for 586/1024 (57.2%) of neonates and in 570/586 (97.3%) cases the clinicians adhered to this recommendation. Blood cultures were obtained for 182/186 (97.8%) infants who started antibiotics and only four were positive, for group B streptococci. Antibiotic treatment was continued for more than 3 days in 56/178 (31.5%) neonates, despite a negative blood culture. Low adherence to the Dutch guidelines meant that the majority of neonates did not receive the antibiotic treatment that was recommended, while some antibiotic use was prolonged despite negative blood cultures. The guidelines need to be revised.

Identifiants

pubmed: 32686180
doi: 10.1111/apa.15488
pmc: PMC7984438
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

791-798

Informations de copyright

© 2020 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.

Références

Lancet. 2017 Aug 26;390(10097):871-881
pubmed: 28711318
Pediatrics. 2012 Sep;130(3):587-97
pubmed: 22926177
Pediatr Infect Dis J. 2020 May;39(5):438-443
pubmed: 32301920
J Hosp Infect. 2018 Apr;98(4):425-428
pubmed: 29258918
Arch Dis Child Fetal Neonatal Ed. 2020 Mar;105(2):118-122
pubmed: 31296696
Swiss Med Wkly. 2013 Sep 19;143:w13873
pubmed: 24089151
Pediatrics. 2019 Nov;144(5):
pubmed: 31641017
Evid Based Nurs. 2018 Apr;21(2):46
pubmed: 29459384
Pediatrics. 2017 Oct;140(4):
pubmed: 28928289
Arch Dis Child Fetal Neonatal Ed. 2015 May;100(3):F248-9
pubmed: 25079114
JAMA Pediatr. 2019 Sep 3;:
pubmed: 31479103
J Infect. 2016 Jul 5;72 Suppl:S77-82
pubmed: 27222092
Pediatrics. 2019 Aug;144(2):
pubmed: 31285392
World J Clin Pediatr. 2016 Nov 8;5(4):358-364
pubmed: 27872823
Arch Dis Child Fetal Neonatal Ed. 2015 Mar;100(2):F185
pubmed: 25526912
Pediatrics. 2018 Dec;142(6):
pubmed: 30455342
Curr Opin Pediatr. 2016 Apr;28(2):135-40
pubmed: 26766602
Front Pediatr. 2018 Oct 09;6:285
pubmed: 30356671
Eur J Pediatr. 2018 May;177(5):741-746
pubmed: 29455368
Hosp Pediatr. 2019 Apr;9(4):227-233
pubmed: 30833294
Lancet. 2017 Oct 14;390(10104):1770-1780
pubmed: 28434651
Pediatrics. 2017 Nov;140(5):
pubmed: 28982710
Acta Paediatr. 2021 Mar;110(3):791-798
pubmed: 32686180
Pediatr Res. 2018 Jan;83(1-1):13-15
pubmed: 29019470
MMWR Recomm Rep. 2010 Nov 19;59(RR-10):1-36
pubmed: 21088663
Lancet Infect Dis. 2016 Oct;16(10):1178-1184
pubmed: 27452782
Swiss Med Wkly. 2014 Jun 25;144:w13981
pubmed: 24964177

Auteurs

Bo M van der Weijden (BM)

Department of Paediatrics, Tergooi Hospital, Blaricum, The Netherlands.

Niek B Achten (NB)

Department of Paediatrics, Tergooi Hospital, Blaricum, The Netherlands.
Department of Paediatrics, Emma Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands.

Jolita Bekhof (J)

Department of Paediatrics, Isala Hospital, Zwolle, The Netherlands.

Esther E Evers (EE)

Department of Paediatrics, Isala Hospital, Zwolle, The Netherlands.

Mylène Berk (M)

Department of Paediatrics, Spaarne Hospital, Haarlem, The Netherlands.

Arvid W A Kamps (AWA)

Department of Paediatrics, Martini Hospital, Groningen, The Netherlands.

Maarten Rijpert (M)

Department of Paediatrics, Zaans Medical Centre, Zaandam, The Netherlands.

Gavin W Ten Tusscher (GW)

Department of Paediatrics, Dijklander Hospital, Hoorn, The Netherlands.

Marlies A van Houten (MA)

Department of Paediatrics, Spaarne Hospital, Haarlem, The Netherlands.

Frans B Plötz (FB)

Department of Paediatrics, Tergooi Hospital, Blaricum, The Netherlands.
Department of Paediatrics, Emma Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH